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ABSTRACT

FOXP3
+ regulatory T cells (Tregs) are central to the maintenance of immunological homeostasis and tolerance. It has long been known that Sertoli cells are endowed with immune suppressive properties; however, the underlying mechanisms as well as the effective nature and role of soluble factors secreted by Sertoli cells have not been fully elucidated as yet. We hypothesized that conditioned medium from primary mouse Sertoli cells (SCCM) may be able and sufficient to induce Tregs. By culturing CD4 + CD25
À EGFP À T splenocytes purified from FOXP3-EGFP knock-in mice in SCCM, here we show, by flow cytometry and suppression assay, the conversion of peripheral CD4 + FOXP3 À T cells into functional CD4 + FOXP3 + Tregs. We also demonstrate that the Notch/Jagged1 axis is involved in regulating the de novo generation of Tregs although this process is transforming growth factor-beta1 (TGF-B) dependent. In particular, we identified by Western blot analysis a soluble form of JAGGED1 (JAG1) in SCCM that significantly influences the induction of Tregs, as demonstrated by performing the conversion assay in presence of a JAG1-specific neutralizing antibody. In addition, we show that SCCM modulates the Notch pathway in converted Tregs by triggering the recruitment of the Notchspecific transcription factor CSL/RBP-Jk to the Foxp3 promoter and by inducing the Notch target gene Hey1, as shown by chromatin immunoprecipitation assay and by real time-RT-PCR experiments, respectively. Overall, these results contribute to a better understanding of the molecular mechanisms involved in Sertoli cell-mediated immune tolerance and provide a novel approach to generate ex vivo functional Tregs for therapeutic purpose.
INTRODUCTION
The testis is regarded as an immunologically privileged site where physiological mechanisms must be active in preventing immune responses against germ cells expressing highly specific antigens and in protecting the reproductive function from inflammatory stimuli [1, 2] . Different reports suggest that testicular immune privilege may be a localized phenomenon affecting both T-cell activation and maturation events, which appears to be due to a continuous process of immune suppression. In this regard, mechanisms reported so far include persistence of physiological self-antigen [3] , inadequate or inappropriate signals provided by interstitial macrophages [4, 5] , local production of immunosuppressive molecules [6, 7] and cytokines, such as TGF-B and activin [8, 9] . The cellular components mainly responsible for immune tolerance in the testis are the Sertoli cells (SCs) [10] . SCs are somatic cells of the seminiferous epithelium that form the blood-testis barrier and enclose autoantigenic germ cells. Importantly, SCs are capable of retaining immunoprotective properties outside of the testis by creating an immune-privileged ectopic site. Such immunosuppressive properties have been exploited in in vivo models of autoimmune diseases: isolated porcine SCs, administered alone in highly biocompatible microcapsules, led to diabetes prevention and reversion in overtly diabetic NOD mice through the generation of regulatory T cells (Tregs) [11] . Moreover, SCs can be genetically engineered to process and secrete biologically active proteins retaining their immune privilege potential, thus suggesting their use in delivering therapeutic proteins and avoiding tissue rejection [12] . However, the nature of soluble factors secreted by SCs and their effectiveness on Treg induction has not been fully investigated.
CD4 þ FOXP3 þ Tregs play a key role in the maintenance of immunological tolerance to both self-and foreign antigens by suppressing T cell responses and preventing autoimmunity or allograft rejection [13] . Tregs can also be generated in the periphery from the naive T cell pool: these induced Tregs (iTregs) are necessary to maintain the immunological tolerance to self [14] . TGF-B, in the context of TCR stimulation, promotes FOXP3 expression in naive peripheral CD4 þ T cells and converts them into FOXP3
þ Tregs [15] . However, the relevance of TGF-B signaling as well as of other pathways in regulating iTreg behavior under physiological conditions remains unclear [16] . The ability to generate iTregs from the naive pool has been previously demonstrated in the gut [17] , but evidence is lacking that this conversion may take place in other mucosal systems. Thus, it will be interesting to clarify in which organs the de novo generation of Tregs occurs.
It has been shown that Notch signaling, and in particular Notch1, cooperates with TGF-B in the regulation of FOXP3 expression during the generation of iTregs and influences their maintenance both in vivo and in vitro [18] . The Notch family is a group of evolutionary conserved type I transmembrane receptors involved in cell fate decisions in a variety of systems [19] . Following ligand-dependent ectodomain shedding catalyzed by ADAM metalloproteases, the Notch receptor is activated through the enzymatic cleavage by the c-secretase complex. This finally results in the release of the intracellular portion of Notch that translocates to the nucleus, displaces corepressors from DNA-bound transcription factor CSL/RBPJk, and recruits coactivators, leading to transcriptional activation of target genes.
We have recently demonstrated that, besides Notch1, Notch3 constitutive activation in a transgenic mouse model was associated with an increase in numbers, suppressive function, and FOXP3 expression of naturally occurring Tregs [20, 21] , and that Notch3 signaling directly influences Foxp3 promoter expression [22] . Moreover, it was shown that the Notch1/JAG1 interaction facilitates TGF-B-mediated effector function of Tregs [23] . However, the potential role of the Notch pathway in the induction of Tregs mediated by SCs has not been explored to date.
In the present paper, we demonstrate that serum-free conditioned medium from primary SC (SCCM) cultures is able per se to trigger CD4
þ Tregs. Moreover, SCCM contains a soluble form of Jagged-1 involved in the regulation of this process, thus indicating that the Notch/Jagged pathway participates to the TGF-B-dependent SC-induced generation of Tregs.
MATERIALS AND METHODS
Mice
Sertoli cells were prepared from 2-wk-old wild-type (wt) CD1 male mice (Charles River Laboratories, Inc., Calco, Italy). Lymphocytes for culture experiments in minimal essential medium (MEM) or SCCM were obtained from 8-to 12-wk-old wt CD1, FOXP3-EGFP, or SMAD3 À/À male mice. FOXP3-EGFP mice, kindly provided by Dr. B. Malissen [24] , and SMAD3 À/À mice [25] were described elsewhere, and both of them had the C57/Bl6 genetic background.
Animals were bred and maintained in the Department of Experimental Medicine Animal Facility of Sapienza University. All the in vivo studies were conducted in compliance with institutional guidelines for animal care and use, and animal protocols were approved by the ethical committee of Sapienza University of Rome.
Sertoli Cell Cultures
Sertoli cells were prepared from CD1 mice as previously described [26] . Briefly, testes from 2-wk-old animals were sequentially digested for 20 min, first with Hanks solution containing 0.25% trypsin plus 10 lg/ml DNase and then with Hanks solution supplemented with 0.1% collagenase plus 10 lg/ml DNase to remove interstitial tissue and peritubular cells. DNase, collagenase, and trypsin were obtained from Roche Molecular Biochemicals (Mannheim, Germany). Fragments of seminiferous epithelium, mainly composed of SC, were cultured at 328C in 95% air and 5% CO 2 in serum-free MEM (Gibco, Life Technologies, Eugene, OR). MEM was supplemented with 1.2 g/L sodium bicarbonate, 2 mM L-glutamine, 100 units (U)/ml penicillin, 100 lg/ml streptomycin, 10 mM HEPES, MEM Non-essential Amino Acid Solution (1003) M7145 (Sigma-Aldrich), 10 lg/ml gentamicin. After 3 days, the cultures were subjected to hypotonic shock by incubation at room temperature with 20 mM Tris-HCl buffer, pH 7.4 (Sigma-Aldrich, St. Louis, MO) for 150 sec to remove residual germ cells. Sertoli cell cultures were routinely checked for possible contamination by macrophages and peritubular smooth muscle cells by means of indirect immunofluorescence with anti-macrophage monoclonal antibody (Mac-1 antigen CD11b, 0.125 lg/10 6 cells; Roche, Basel, Switzerland) and by histochemical detection of alkaline phosphatase activity. In all the experiments, the monolayers used were composed of at least 95% pure SC. Sertoli cells were plated on 6-multiwell plates. On the fourth day of culture, culture serum-free medium was replaced with 1 ml/well fresh serumfree medium for 24 h conditioning. For each experiment, SCCM from the different wells was collected after 24 h, pooled, centrifuged at 3000 3 g for 5 min at 48C, and the supernatant was stored at À808C.
Lymphocyte Preparation and Cell Sorting
Single-cell suspension of splenocytes was prepared and CD4 þ T cells were purified by using CD4 þ T cell isolation kit (Miltenyi Biotec, Inc., Auburn, CA) according to the manufacturer's instructions (purity .95%). In the experiments performed with FOXP3-EGFP mice, magnetically enriched CD4 þ T cells were appropriately stained, and
populations were purified (purity .98%) with a FACSAria cell sorter (BD Biosciences, Franklin Lakes, NJ).
Lymphocyte Cultures in SCCM
/well) were purified as described above and cultured on 3 lg/ml anti-CD3 (145-2C11) (eBioscience, San Diego, CA) precoated wells (24-multiwells) at 378C for 4 days in MEM or in SCCM, supplemented with 10% fetal calf serum, 2 mM Lglutamine, 100 U/ml penicillin, 100 lg/ml streptomycin, 10 mM HEPES, 50 lM 2-mercaptoethanol, 1 mM pyruvate, and 15 lg/ml gentamicin (all from Sigma-Aldrich) in presence of 2 lg/ml soluble anti-mouse CD28 (i.e., the 37.51 monoclonal antibody) (eBioscience). In some sets of experiments, cell cultures were conducted in the presence of ALK inhibitor SB431542 (2 lM), SMAD3 inhibitor SIS3 (3.3 lM), c-secretase inhibitor I (GSI, 500 nM) (all from Calbiochem-Merck, Germany) or dimethyl sulfoxide (DMSO; Sigma-Aldrich). In another set of experiments, human recombinant IL-2 (BD Biosciences, Bedford, MA), was added at 100 U/ml. The concentration of SIS3 and GSI was the highest nontoxic concentration obtained from dose-response experiments on lymphocytes cultured in MEM. For JAGGED1 (JAG1) functional studies, cell cultures were conducted in the presence of 90 lg/ml anti-JAG1-neutralizing antibody (HMJ1-29) or relative immunoglobulin G control, both from eBioscience. To assess lymphocyte proliferation, we used carboxyfluorescein diacetate succinimidyl ester (CFSE) (Molecular Probes, Life Technologies, Eugene, OR). Purified T cells were labeled with 2.5 lM for 10 min at 378C and washed three times with complete medium. The intensity of CFSE staining was determined after 4 days culturing via flow cytometric analysis. . Cells were cultured for 72 h in 96-well, round-bottomed plates (Costar, Cambridge, MA) in RPMI 1640 medium supplemented with 10% fetal calf serum, 100 U/ ml penicillin, 100 lg/ml streptomycin, 50 lM 2-mercaptoethanol, 1 mM pyruvate, and anti-CD3 mAb (145-2C11; eBioscience) at the final concentration of 10 lg/ml. To assess lymphocyte proliferation, responder cells were labeled before coculture with 5 lM efluor 670 (eBioscience) according to the manufacturer's instructions. Proliferation was determined via flow cytometric analysis.
Suppression Assay
Whole Cell Extract Preparation and Western Blot Analysis
Total SC lysates were prepared as described [27] by lysing and scraping the cells off the culture plate with Cell Lysis Buffer (New England Biolabs, Beverly, MA), containing 1 lg/ml leupeptin and 1 mM phenylmethanesulfonylfluoride (Sigma-Aldrich). Positive control of full-length JAG1 was represented by whole cell lysates obtained from HEK293 cells transfected with the plasmid p-BABE-J1 [28] . Western blot analysis was performed on 40 lg of total protein extracts by using anti-JAG1 (C20-sc6011; Santa Cruz Biotechnology, Santa Cruz, CA) at a final concentration of 0.4 lg/ml. The soluble form of JAG1 has been identified in SCCM compared with the negative control represented by medium only. Positive control was represented by whole cell lysates obtained from HEK293 cells transfected with the plasmid p-BABE-J ex [28] . Before protein analysis, SCCM was concentrated by using Amicon Ultra 10K column (cutoff ¼ 10 000 Da; Millipore, Billerica, MA) after adding protease inhibitor 503 (Sigma-Aldrich), and an equal amount of protein (15 lg) CAMPESE ET AL.
was blotted with a rabbit polyclonal antibody against the N-terminal region of JAG1 (ab7771; Abcam, Cambridge, U.K.) at a final concentration of 3.33 lg/ ml.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) assay was performed on CD4 þ CD25 À EGFP À T splenocytes from FOXP3-EGFP mice, sorted as described above, and cultured on anti-CD3 precoated wells either in MEM or in SCCM for 24 h. Protein complexes were cross-linked to DNA in living nuclei with formaldehyde to a final concentration of 1%. The samples were then processed with ChIP assay kit (Millipore) following the manufacturer's instructions. Five micrograms of specific antibody (anti-RBP-jk sc-28713X or anti-NOTCH1 sc-6014-R) or control IgG (normal rabbit IgG, sc-2027), all from Santa Cruz Biotechnology, were added. Immunoprecipitated DNA was eluted and analyzed by PCR using the following primers including the RBP-Jk/CSL core site: 5 0 -ACCCTGCAATTATCAGCACA-3 0 and 5 0 -CCTTGGTGAAGT GGACTGCT-3 0 .
RNA Isolation and Real-Time RT-PCR
The wt CD4 þ T splenocytes (in 0.3 3 10 6 /well) were cultured for 24 h in MEM or in SCCM in the presence of JAG1-neutralizing antibody or IgG control as described above. In another set of experiments, CD4
þ CD25
À EGFP À T splenocytes from FOXP3-EGFP mice were cultured for 24 h in SCCM in the presence of GSI or DMSO. Cells were harvested, washed, and total RNA was extracted by using RNeasy Micro Kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. Complementary DNA synthesis was performed using high-capacity cDNA reverse transcription kit from Applied Biosystems (Foster City, CA). Quantitative PCR analysis of mRNA expression of Hey1 and Hprt (as endogenous control) was performed using the StepOne Plus RealTime PCR System and TaqMan gene expression assays according to the manufacturer's instructions (Applied Biosystems).
Cell Transfection and Luciferase Assay
Transient transfection experiments of preT2017 T cell line [29] cultured in MEM or SCCM was performed using the Lipofectamine 2000 kit (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions. The pGL3-FOXP3 luciferase reporter (0.8 lg) plasmid [22] was transfected in combination with RBP-Jk DN R218H [30] or control empty vector (1.5 lg). Renilla luciferase reporter vector pTK-Renilla-Luc (0.5 ng) was also incorporated into each transfection (Promega, Madison, WI). At 24 h posttransfection, Firefly-and pTK-Renilla-Luc activities were measured in each sample with the Dual Luciferase Assay System (Promega) using a Victor X light luminescence plate reader (Perkin Elmer, Waltham, MA). The FOXP3-specific luciferase activity was determined in triplicate samples and was normalized on the Renilla luciferase activity.
Flow Cytometry
At the indicated times, cultured T cells were harvested and stained with anti-mouse CD4efluor450-conjugated (RM4-5, 0.125 lg/10 6 cells) and antimouse/rat FOXP3 biotin-conjugated (FJK-16s, 0.1 lg/10 6 cells) (all from eBioscience) followed by streptavidin-PeCy5-conjugated (BD Biosciences) staining. Intracellular FOXP3 staining was performed by using an intracellular FOXP3 detection kit (eBioscience) according to the manufacturer's instructions. Dead cells were excluded by staining with NIR (Live Dead Fixable Near-IR Dead Cell stain kit; Invitrogen, Eugene, OR) according to the manufacturer's instructions. Cells were gated using forward versus side scatter and NIR to exclude dead cells and debris.
For SC flow cytometric analysis, cells were detached with 0.025% trypsin/ 0.02% ethylenediaminetetraacetic acid and washed with cold phosphatebuffered saline (PBS) plus 1% bovine serum albumin. For detection of JAG1 expression on the cell surface, we used the hamster anti-JAG1 PE-conjugated monoclonal antibody (HMJ1-29, 0.5 lg/10 6 cells) or the appropriate isotypic control (0.5 lg/10 6 cells, both from eBioscience). Samples were run on a Cyan cytometer (Beckman Coulter, Fullerton, CA), and data analysis was performed by using the FCS3 software (DeNovo, Los Angeles, CA).
Statistical Analysis
A Student t-test for paired samples was used to assess differences among groups; P , 0.05 was considered significant.
RESULTS
SCCM Induces the De Novo Conversion of CD4
We have previously demonstrated that soluble factors present in SCCM inhibit the proliferation of in vitro activated T lymphocytes [6, 31] . In order to clarify whether soluble factors produced by SCs can also induce Tregs, we set up the following experimental model. Enriched CD4 þ T cells obtained from mouse spleens (see Materials and Methods) were cultured on anti-CD3 precoated wells in the presence of soluble anti-CD28 either in control medium (MEM) Fig. 1C ) that was statistically significant not only in percentages, but also in absolute numbers (Fig. 1D , left and right panels, respectively). In another set of experiments, performed by culturing CD4 þ CD25 þ EGFP þ T splenocytes from FOXP3-EGFP mice in SCCM, no increase in their absolute numbers was observed (data not shown), suggesting that SCCM does not exert significant effects on the proliferation/expansion of naturally occurring Tregs.
In order to ascertain if SCCM-iTregs were functional, we tested their suppressive activity in vitro. The suppression assay was performed by culturing different ratios (0:1, 1:2, and 1:
The results showed that the majority of responder cells proliferated in the absence of Tregs (4% of undivided cells; Fig. 1E, upper  panel) , whereas the coculture with increasing numbers of Tregs strongly inhibited their proliferation in a dose-dependent manner (28% and 55% of undivided cells at 1:2 and 1:1 ratio, respectively; Fig. 1E , middle and lower panels, respectively). In Figure 1F , we show a graph summarizing the data obtained in all the suppressive experiments performed. Collectively, these data indicate that SCCM induced the appearance of functional Tregs.
Treg Induction Sustained by SCCM Exposure Is TGF-BDependent
Sertoli cells produce a wide variety of proteins, including TGF-B [32] . FOXP3
þ Tregs can be generated in vitro from CD4 þ FOXP3 À T cells in the presence of TGF-B [15] . Moreover, it was demonstrated that in vivo delivery of SCs protects from autoimmunity by generation of Tregs in a TGF-B-dependent manner [11] . To verify whether in our model TGF-B may be responsible for the induction of FOXP3 þ cells, we decided to repeat our experiments of iTreg generation in the presence of a potent and selective inhibitor of the TGF-Bcognate ALK receptors (SB431542) [33] . 
SB431542. The percentage of EGFP
þ cells decreased from 52.6% in SCCM-cultured samples to 2.68% in SCCM-cultured plus SB431542-treated cells to a level comparable to that of MEM-cultured controls (1.65%; Fig. 2A ). These data reinforced the role of TGF-B produced in some immune-privileged tissues and organs, such as testis, as the main inducer of FOXP3 þ Tregs. In lymphocytes, TGF-B binds to its cognate receptor complex composed of type I (ALK5) and type II receptors activating SMAD-dependent or independent pathways. Because cellular response to TGF-B varies depending on the context of the stimulus and a recent paper suggested that SMAD3 is specifically involved in the TGF-B/Notch cooperation during FOXP3 induction [18] , we were interested in understanding whether a SMAD-dependent pathway is activated in our model. CD4
þ T splenocytes were cultured in control medium or in SCCM with or without the specific SMAD3 inhibitor SIS3. Figure 2B ( À/À versus wt mice (Fig. 2B, right panel) . Thus, SCCM induces FOXP3 expression in a partially SMAD3-dependent manner.
The Notch Pathway Regulates the SCCM-Dependent De Novo Generation of Tregs
Notch signaling has recently been shown to be involved in the transcriptional control of Foxp3 gene [18, 21, 22] . Moreover, cross-talk between Notch and TGFÀb pathways has been described in the induction of FOXP3 expression and regulatory phenotype in peripheral T cells in vitro [18] .
In order to ascertain whether Notch signaling might be involved in FOXP3 induction triggered by SCCM, CD4 þ CD25 À EGFP À sorted T splenocytes were cultured in presence of control medium or SCCM with or without gamma secretase inhibitor (GSI), thus preventing Notch activation. Figure 3A shows that GSI inhibited the SCCM-mediated generation of FOXP3-positive cells, being the percentage of these cells significantly lower in the presence of GSI, compared to that of the DMSO samples. These data suggest that the Notch system was involved in the increase of FOXP3 þ Tregs induced by SCCM. To verify that GSI treatment indeed inhibits NOTCH activity, we evaluated the expression of the NOTCH target gene Hey1. Our results found evidence that Hey1 RNA expression levels were significantly decreased in GSI-treated cells compared to DMSO controls (Fig. 3B) . Moreover, we showed that the addition of exogenous IL-2 to the GSI-treated 
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cultures did not affect the percentage of FOXP3 þ Tregs induced by SCCM (Fig. 3C) À EGFP À T splenocytes cultured either in MEM or in SCCM were processed for ChIP assay using a-CSL (CSL) or a-NOTCH1 (N1) antibody or relative IgG (IgG) control. NCT, no template control. The results are representative of three independent experiments. E) Foxp3 luciferase reporter activity of preT2017 cells cultured in MEM or in SCCM and cotransfected with dominant negative RBP-J (DN RBP-J) or empty control (CTR) vector. The luciferase activity of MEM-cultured preT2017 cells was set as 1. Mean values 6 SEM are shown, and they were obtained from three independent experiments, each in triplicate. *P , 0.05.
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MEM or in SCCM. We observed that at 24 h of culturing the percentage of Tregs was ,1% in MEM-cultured samples versus 15.2% 6 2.1% in SCCM-cultured cells (data not shown). We analyzed the highly conserved proximal promoter region of murine Foxp3 gene, previously described [34] and containing a CSL/RBP-Jk consensus site (5 0 -TTTCCCA-3 0 ) located between À8 and À2 bp upstream of the transcriptional start site (see Fig. 3D, upper panel) . We showed that CSL/ RBP-Jk binding to this site was virtually absent in samples from MEM-cultured cells (Fig. 3D, lower panels) , as well as in T0 samples (data not shown), whereas it was clearly detectable in samples from cells exposed to SCCM; we also showed the occupancy of the same Foxp3 promoter region by NOTCH1 in cells cultured with SCCM, thus providing further argument supporting the Notch-regulated induction of Foxp3 promoter.
To assess more directly the role of SCCM in regulating RBP-Jk-dependent Foxp3 transcription, we performed cotransfection experiments in the preT2017 T cell line [29] , with a firefly-luciferase reporter vector (pGL3-Foxp3), containing the 600 bp upstream of the mouse Foxp3 promoter [22] , in combination with a dominant-negative RBP-Jk expression vector or an empty control vector. Our data demonstrated that exposure to SCCM significantly increased Foxp3 luciferase reporter activity in preT2017 with respect to MEM-cultured controls. More importantly, SCCM-induced Foxp3 luciferase reporter activity was significantly reduced in preT2017 T cells cotransfected with dominant-negative RBP-Jk vector with respect to empty vector cotransfected controls, demonstrating that the up-regulation of FOXP3 expression triggered by SCCM was prevented in the absence of RBP-Jk (Fig. 3E) . To our knowledge, these data represent the first demonstration that Notch pathway is able to regulate the generation of Tregs induced by SC by controlling FOXP3 expression at the transcriptional level.
SCCM Contains a Soluble Form of JAG1 That Is Involved in the De Novo Generation of Tregs
Several groups demonstrated that exposure to JAG1 ligands induces generation of cells with immunoregulatory function (see [35] and references therein). Furthermore, a soluble form of JAG1 ectodomain released in conditioned media was described, and its different biological activities were postulated [36] or demonstrated in various systems other than immune cell differentiation [37, 38] . Thus, to gain more insight into the mechanisms by which Notch signaling influences SCCMdependent generation of Tregs, we hypothesized that SCCM may contain a soluble form of JAG1 as a trigger for Notchsignaling activation on Tregs. We demonstrated the expression of JAGGED full-length in SC total cell lysates (Fig. 4A, upper  panel) , in agreement with [39] . Moreover, we showed for the first time that SCCM contained a soluble form of JAG1 (Fig.  4A , lower panel) and that its inhibition was able to revert the SCCM-dependent FOXP3 þ cell induction (Fig. 4B) . Indeed, the addition of specific JAG1-neutralizing antibody to the SCCM cultured CD4 þ CD25 À EGFP À T splenocytes from FOXP3-EGFP mice induced an about 30% reduction in the percentage of EGFP þ cells after 4 days compared to that of the IgG isotype-treated controls. Furthermore, we demonstrated that JAG1 ligand was expressed on SC surface (Fig. 4C, left  panel) , but notably, it was virtually absent on cell surface of either CD4
þ CD25 À EGFP À T splenocytes (in accordance with [23] ) at the beginning of the culture or SCCM-induced EGFP þ Tregs at 4 days (Fig. 4C, middle and right panels, respectively) . Then, in order to address if soluble JAG1 in SCCM was able to activate Notch signaling on target cells, we evaluated the expression of the Notch target gene Hey1 by real-time RT-PCR on total RNA extracted from CD4 þ T splenocytes after 24 h culturing either in MEM or SCCM in the presence of JAG1-neutralizing antibody or control IgG (Fig. 4D) . Our results found evidence that after exposure to SCCM there was a significant fold induction of Hey1 expression in CD4 þ T cells compared to that observed in MEM-cultured controls. Furthermore, this induction was significantly inhibited when SCCM-cultured CD4 þ T cells were cultured in the presence of JAG1-neutralizing antibody. In order to get more insight into soluble JAG1 function, we first excluded that it affected cell viability because SCCM-cultured CD4þ T cells in the presence of JAG1-neutralizing antibody or control IgG showed the same percentage of dead cells, evaluated by 7-aminoactinomycin D staining (data not shown). Then, we assessed the effect of the neutralization of soluble JAG1 in SCCM on CD4
þ FOXP3 þ T cell proliferation. To this aim, sorted CD4 þ CD25
À EGFP À T splenocytes from FOXP3-EGFP mice were labeled with efluor670 and cultured in SCCM in the presence of JAG1-neutralizing antibody or control IgG. Data in Figure 4E show that CD4
þ EGFP þ T cell proliferation was significantly inhibited in the presence of JAG1-neutralizing antibody, being the undivided cells percentage increased in anti-JAG1 treated cells compared to that observed in IgG-treated controls. Collectively, these results demonstrated that the biological effects on Treg de novo generation were specifically exerted by the soluble form of JAG1 released into the SCCM and that soluble JAG1 affected Treg proliferation.
DISCUSSION
In the present paper, we analyzed the mechanisms underlying the suppressive ability of SCs. Our current data sheds more insight into what has already been known about the role of SCs in the establishment of testicular immune privilege. Indeed, we show that SCCM is able to strongly induce the conversion of CD4 þ CD25 À FOXP3 À T cells into functional and proliferating Tregs through a TGF-B-dependent mechanism. Several reports demonstrated that SCs are able to secrete bioactive TGF-B in vitro [32] and that TGF-B is important in testicular immune suppression [9] . It is also widely accepted that, in in vitro models, TGF-B is able to trigger the conversion of peripheral CD4 þ FOXP3 À T cells into Tregs. However, important questions to address are related to experimentally test whether substantial amounts of TGF-B displayed by some immune-privileged tissues and organs can facilitate the de novo generation of Tregs and, as well, to identify the factors able to cooperate with TGF-B in immune-privileged sites. To date, the organs in which the generation of FOXP3
þ T cells has been demonstrated are the gut [17, [40] [41] [42] , the liver [43] , and the eye [44] . Thus, in this regard, our data reveal the testis as a novel site in which the TGF-B-dependent conversion into Tregs may take place. We also demonstrate for the first time that soluble factors contained in SCCM are sufficient to generate functional iTregs, thus suggesting that a minimal in vitro system, based on primary SCs, may be exploited to induce sufficient amounts of immune-suppressive cells for designing in vivo therapeutic interventions. This could represent an alternative approach to other attempts of using the in vivo delivery of SCs for therapy against autoimmune diseases [11] . Finally, we identified JAG1 as a novel soluble factor that is released by SCs in the culture medium and that is able to significantly regulate the de novo generation of Tregs. It was already known that JAG1 is expressed in SCs [39] and that the forced overexpression of human JAG1 by murine antigen-presenting cell or human B lymphocytes induces Tregs [45, 46] . However, our data reveal for the first time that primary SC cultures constitutively produce amounts of the soluble form of JAG1 and that this form has a novel function in the triggering of Treg differentiation.
Regarding to the mechanism involved in the generation of SCCM-iTregs, we reported that soluble JAG1 in SCCM is able to activate Notch signaling on target cells, that the recruitment of CSL/RBP-Jk and NOTCH1 to the Foxp3 promoter was induced by SCCM, and that a dominant negative form of RBPJk significantly inhibits the SCCM-induced Foxp3 promoter activity. Collectively, these data strongly suggest that the Notch/JAG1 axis regulates the SCCM-driven induction of iTregs by controlling the expression of Foxp3 at the transcriptional level via RBP-Jk.
An important issue to solve is the relationship between TGF-B and Notch/Jagged signaling during Treg differentiation. It is well-known that the peripheral induction of Treg differentiation is strictly TGF-B-dependent. Our data clearly confirm that also in our system TGF-B represents the master regulator of iTreg generation. However, a crucial point of investigation is the characterization of specific second signals operating in different microenvironments, influencing the intensity and the duration of immunosuppressive signals exerted by TGF-B-iTregs. Interestingly, many literature data sustain a role of Notch-signaling activation in improving both the function and the survival of Tregs during their development [20, 21, 47, 48] . Thus, the possibility remains that the exposure to JAG1 may represent an important mechanism to achieve Notch activation and to correctly set up the functions for induced Tregs, even in the context of an already established TGF-B-dependent generation of Tregs.
Recently, the importance of the soluble form of JAG1 has been highlighted [49] , demonstrating that endothelial cells promote the cancer stem cell phenotype of human colorectal cancer cells by triggering Notch signaling through soluble JAGGED-1 released in the tumor microenvironment independently from cell-cell contact. In agreement, we demonstrate that SCs produce a soluble form of JAG1 that is able to activate Notch signaling in CD4 þ T lymphocytes, contributing to their conversion in iTregs. Moreover, we suggest that JAG1 may be involved in regulating the proliferation of iTregs. Overall, we think that our data support the notion that soluble factors may act on different targets in specific microenvironments, such as the testis, and that their modulation can be exploited as a therapeutic tool. Interestingly, it has been demonstrated that Notch signaling is active in SC and it is required for the maintenance of germ cell homeostasis [50] .
In conclusion, here we show that SCCM exposure induces Tregs with powerful suppressive effects. We propose that, besides the engraftment of SCs themselves, our in vitro system may provide a novel approach to generate functional Tregs to be used in pathological settings in which the restoration of immune suppression may be helpful, such as autoimmune diseases. This could have relevant clinical implications. Indeed, given the low number of Tregs derived from patients, the development of therapeutic protocols based on Treg-adoptive transfer have been hampered by the need to generate ex novo high numbers of functional Tregs from non-Treg cells and/or to expand Tregs ex vivo. Certainly, a complex balance between immune-modulating molecules is responsible for the immune protection mediated by SCs. To this regard, our data start discriminating between the pivotal role of TGF-B and the significant involvement of the Notch/JAG1 axis in modulating this process, thus contributing to a better understanding of the molecular mechanisms that determine the SCs' ability to establish testicular immune tolerance. 
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